Furo[3,2-C]pyridines

US8022206B2 · kind B2 · utility

Assignee

• OSI Pharmaceuticals, LLC · US

Inventors

• An-Hu Li · New York, US
• Arno G. Steinig · East Northport, US
• Andrew Kleinberg · Roslyn Heights, US
• Qinghua Weng · Farmingdale, US
• Mark J. Mulvihill · Melville, US
• Jing Wang · Acton, US
• Xin Chen · Lexington, US
• Ti-Shiang Wang · Lexington, US
• Hanqing Dong · Madison, US
• Meizhong Jin · Dix Hills, US

Key dates

• Filing date: Feb 6, 2009
• Grant date: Sep 20, 2011
• Expiry date: Oct 15, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Furo[3,2-c]Pyridine and Thieno[3,2-c]pyridine compounds of Formula I, and pharmaceutically acceptable salts thereof, preparation, intermediates, pharmaceutical compositions, and use, such as in disease treatment, including cancers, including conditions in which EMT is involved, including conditions mediated by protein kinase activity such as RON and/or MET.